- Home
- RANI vs OKYO Comparison
RANI vs OKYO Comparison
Compare RANI & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RANI
- OKYO
- Stock Information
- Founded
- RANI 2012
- OKYO 2007
- Country
- RANI United States
- OKYO United Kingdom
- Employees
- RANI N/A
- OKYO N/A
- Industry
- RANI Medicinal Chemicals and Botanical Products
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RANI Health Care
- OKYO Health Care
- Exchange
- RANI Nasdaq
- OKYO Nasdaq
- Market Cap
- RANI 41.6M
- OKYO 38.6M
- IPO Year
- RANI 2021
- OKYO 2022
- Fundamental
- Price
- RANI $1.31
- OKYO $1.04
- Analyst Decision
- RANI Strong Buy
- OKYO Strong Buy
- Analyst Count
- RANI 5
- OKYO 1
- Target Price
- RANI $11.80
- OKYO $7.00
- AVG Volume (30 Days)
- RANI 420.9K
- OKYO 93.8K
- Earning Date
- RANI 11-14-2024
- OKYO 01-28-2025
- Dividend Yield
- RANI N/A
- OKYO N/A
- EPS Growth
- RANI N/A
- OKYO N/A
- EPS
- RANI N/A
- OKYO N/A
- Revenue
- RANI N/A
- OKYO N/A
- Revenue This Year
- RANI N/A
- OKYO N/A
- Revenue Next Year
- RANI N/A
- OKYO N/A
- P/E Ratio
- RANI N/A
- OKYO N/A
- Revenue Growth
- RANI N/A
- OKYO N/A
- 52 Week Low
- RANI $1.24
- OKYO $0.81
- 52 Week High
- RANI $8.75
- OKYO $1.90
- Technical
- Relative Strength Index (RSI)
- RANI 35.89
- OKYO 45.08
- Support Level
- RANI $1.24
- OKYO $1.00
- Resistance Level
- RANI $1.61
- OKYO $1.35
- Average True Range (ATR)
- RANI 0.11
- OKYO 0.10
- MACD
- RANI 0.02
- OKYO -0.01
- Stochastic Oscillator
- RANI 18.92
- OKYO 11.43
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.